Glanbia plc – LSE:GLB.L
Glanbia stock price today
Glanbia stock price monthly change
Glanbia stock price quarterly change
Glanbia stock price yearly change
Glanbia key metrics
Market Cap | 3.44B |
Enterprise value | 4.15B |
P/E | 16.06 |
EV/Sales | 1.40 |
EV/EBITDA | 12.35 |
Price/Sales | 1.16 |
Price/Book | 1.77 |
PEG ratio | 0.16 |
EPS | 0.69 |
Revenue | 5.64B |
EBITDA | 404.1M |
Income | 199.6M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 7.5% |
Oper. margin | 8.87% |
Gross margin | 27.14% |
EBIT margin | 8.87% |
EBITDA margin | 7.16% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGlanbia stock price history
Glanbia stock forecast
Glanbia financial statements
| Mar 2022 | 1.41B | 49.9M | 3.54% |
|---|---|---|---|
| Jun 2022 | 1.41B | 49.9M | 3.54% |
| Sep 2022 | 1.41B | 49.9M | 3.54% |
| Dec 2022 | 1.41B | 49.9M | 3.54% |
| 2025 | 3.73B | 413.76M | 11.08% |
|---|---|---|---|
| 2026 | 3.90B | 446.09M | 11.41% |
| 2027 | 4.04B | 486.46M | 12.03% |
| 2028 | 4.20B | 0 |
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 36.8% |
|---|
| 2019 | 2.82% |
|---|---|
| 2020 | 3.11% |
| 2021 | 2.53% |
| 2022 | 2.55% |
| 2023 | 2.44% |
| Jun 2022 | 3914500000 | 2.00B | 51.14% |
|---|---|---|---|
| Dec 2022 | 3860100000 | 1.99B | 51.6% |
| Jun 2023 | 3688300000 | 1.61B | 43.88% |
| Dec 2023 | 3799100000 | 1.66B | 43.87% |
| Mar 2022 | 74.57M | -1.9M | -265.52M |
|---|---|---|---|
| Jun 2022 | 74.57M | -1.9M | -265.52M |
| Sep 2022 | 74.57M | -1.9M | -265.52M |
| Dec 2022 | 74.57M | -1.9M | -265.52M |
Glanbia alternative data
| Aug 2023 | 6,163 |
|---|---|
| Sep 2023 | 6,163 |
| Oct 2023 | 6,163 |
| Nov 2023 | 6,163 |
| Dec 2023 | 6,163 |
| Jan 2024 | 6,163 |
| Feb 2024 | 6,163 |
| Mar 2024 | 5,534 |
| Apr 2024 | 5,534 |
| May 2024 | 5,534 |
| Jun 2024 | 5,534 |
| Jul 2024 | 5,534 |
Glanbia other data
| Insider | Compensation |
|---|---|
Ms. Siobhan Talbot (1964) Group MD & Executive Director | $1,970,000 |
Mr. Mark A. Garvey (1964) Group Fin. Director & Executive Director | $1,080,000 |
-
What's the price of Glanbia stock today?
One share of Glanbia stock can currently be purchased for approximately $12.47.
-
When is Glanbia's next earnings date?
Unfortunately, Glanbia's (GLB.L) next earnings date is currently unknown.
-
Does Glanbia pay dividends?
Yes, Glanbia pays dividends and its trailing 12-month yield is 2.74% with 37% payout ratio. The last Glanbia stock dividend of $0 was paid on 6 Sep 2025.
-
How much money does Glanbia make?
Glanbia has a market capitalization of 3.44B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3.85% to 5.43B US dollars.
-
What is Glanbia's stock symbol?
Glanbia plc is traded on the LSE under the ticker symbol "GLB.L".
-
What is Glanbia's primary industry?
Company operates in the Consumer Defensive sector and Packaged Foods industry.
-
How do i buy shares of Glanbia?
Shares of Glanbia can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Glanbia's key executives?
Glanbia's management team includes the following people:
- Ms. Siobhan Talbot Group MD & Executive Director(age: 61, pay: $1,970,000)
- Mr. Mark A. Garvey Group Fin. Director & Executive Director(age: 61, pay: $1,080,000)
-
How many employees does Glanbia have?
As Jul 2024, Glanbia employs 5,534 workers.
-
When Glanbia went public?
Glanbia plc is publicly traded company for more then 25 years since IPO on 4 Jan 2000.
-
What is Glanbia's official website?
The official website for Glanbia is glanbia.com.
-
How can i contact Glanbia?
Glanbia can be reached via phone at +353 56 777 2200.
Glanbia company profile:
Glanbia plc
glanbia.comLSE
5,534
Packaged Foods
Consumer Defensive
Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Kilkenny, R95 E866
:
ISIN: IE0000669501
CUSIP: G39021103
